RAPLON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Raplon, and what generic alternatives are available?
Raplon is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in RAPLON is rapacuronium bromide. Additional details are available on the rapacuronium bromide profile page.
Summary for RAPLON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 553 |
DailyMed Link: | RAPLON at DailyMed |
US Patents and Regulatory Information for RAPLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-002 | Aug 18, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RAPLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-002 | Aug 18, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RAPLON
See the table below for patents covering RAPLON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0571012 | Dérivés de monoquaternaire 2,16-bispipéridinylandrostanes (Monoqaternary 2, 16-bispiperidinylandrostane derivatives) | ⤷ Try a Trial |
Japan | H07267984 | MONO-QUATERNARY SALT DERIVATIVE OF 2,16-BISPIPERIDINYLANDROSTANE | ⤷ Try a Trial |
Japan | 3344764 | ⤷ Try a Trial | |
Mexico | 9302303 | DERIVADOS MONOCUATERNARIOOS DE 2,16-BISPIPERIDINILANDROSTANO. | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |